| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cleft Palate | D002972 | 9 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Contusions | D003288 | 3 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Coronary Thrombosis | D003328 | 7 associated lipids |
| Coronary Vasospasm | D003329 | 9 associated lipids |
| Cough | D003371 | 19 associated lipids |
| Death, Sudden | D003645 | 12 associated lipids |
| Dermatitis, Atopic | D003876 | 19 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Diabetic Angiopathies | D003925 | 20 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetic Retinopathy | D003930 | 39 associated lipids |
| Diseases in Twins | D004200 | 4 associated lipids |
| Disseminated Intravascular Coagulation | D004211 | 7 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Landoni MF et al. | Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. | 1996 | Res. Vet. Sci. | pmid:8819190 |
| Galbraith EA and McKellar QA | Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood. | 1996 | Res. Vet. Sci. | pmid:8819199 |
| Davì G et al. | Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. | 1996 | Thromb. Haemost. | pmid:8819248 |
| Wagner RS et al. | Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. | 1996 | Shock | pmid:8821102 |
| Meenan J et al. | Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. | 1996 | Eur J Gastroenterol Hepatol | pmid:8823572 |
| Watanabe M et al. | [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome]. | 1996 | Nihon Jinzo Gakkai Shi | pmid:8828355 |
| Mitten LA et al. | Phenylbutazone increases right atrial pressure and heart rate of running horses. | 1996 | J. Appl. Physiol. | pmid:8828679 |
| Ishibashi M et al. | Identification of 11-dehydro-2,3-dinorthromboxane B3 in human urine based on the mass spectral properties of 11-dehydrothromboxane B3 and related compounds. | 1995 | Rapid Commun. Mass Spectrom. | pmid:8829476 |
| Mizugaki M et al. | Microdetermination of 11-dehydrothromboxane B3 in human urine by gas chromatography--selected-ion monitoring using (18O2) analogue as an internal standard. | 1995 | Rapid Commun. Mass Spectrom. | pmid:8829485 |
| Myers SI et al. | Long-term resuscitation of hemorrhage/reperfusion injury (H/R) stimulates renal PGE2 release. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8832762 |
| Osiovich H et al. | Cardiopulmonary effects of tumor necrosis factor-alpha in the piglet: influence of cyclooxygenase inhibition. | 1995 | Biol. Neonate | pmid:8835089 |
| Meade CJ et al. | Pulmonary pharmacology of DT-TX 30 SE, a potent selective combined thromboxane synthetase inhibitor and receptor antagonist, in guinea pigs. | 1996 | Jpn. J. Pharmacol. | pmid:8835638 |
| Fylling AC et al. | Kinetic and structural evidence for the identification of 11-hydroxythromboxane B2 dehydrogenase as cytosolic aldehyde dehydrogenase. | 1995 Nov-Dec | Prostaglandins | pmid:8838239 |
| Muller M and Sorrell TC | Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine. | 1995 Nov-Dec | Prostaglandins | pmid:8838240 |
| Stichtenoth DO et al. | Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. | 1995 Nov-Dec | Prostaglandins | pmid:8838242 |
| Nowak J et al. | Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. | 1996 | Clin Physiol | pmid:8842572 |
| Cuiper LL et al. | Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. | 1996 | J. Appl. Physiol. | pmid:8847301 |
| Horiguchi T et al. | Pulmonary responses to heparin-protamine complexes: the effects of age and species. | 1996 | J. Appl. Physiol. | pmid:8847332 |
| Gabriel A et al. | Influence of prostaglandin E1 on tissue ischemia during surgical repair of the abdominal aorta. | 1996 | J. Cardiothorac. Vasc. Anesth. | pmid:8850397 |
| Chen SJ et al. | Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate. | 1996 | Gen. Pharmacol. | pmid:8853295 |
| Quinn JV et al. | Evaluation of enzyme-linked immunosorbent assays for quantitation of eicosanoid mediators of sepsis syndrome. | 1996 | Shock | pmid:8856849 |
| Reale M et al. | Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist. | 1996 | Mol. Cell. Biochem. | pmid:8858567 |
| Bordia T et al. | An evaluation of garlic and onion as antithrombotic agents. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8860105 |
| Pancera P et al. | Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8860111 |
| Kanai H et al. | Serotonin metabolism in patients undergoing hemodialysis. | 1996 | Clin. Nephrol. | pmid:8861800 |
| Siler-Khodr TM et al. | Dose-related action of estradiol on placental prostanoid prediction. | 1996 | Prostaglandins | pmid:8873234 |
| Schaefer WR et al. | Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. | 1996 | Prostaglandins | pmid:8875634 |
| Mustad V et al. | Seasonal variation in parameters related to coronary heart disease risk in young men. | 1996 | Atherosclerosis | pmid:8879440 |
| Selley ML et al. | The effect of cholesterol oxidation products on human platelet aggregation. | 1996 | Thromb. Res. | pmid:8885139 |
| Ziyyat A et al. | Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. | 1996 | Br. J. Pharmacol. | pmid:8886425 |
| GarcÃa-Lafuente A et al. | Bacterial peptides enhance inflammatory activity in a rat model of colitis. | 1996 | Digestion | pmid:8886582 |
| Carbajal D et al. | Possible cytoprotective mechanism in rats of D-002, an anti-ulcerogenic product isolated from beeswax. | 1996 | J. Pharm. Pharmacol. | pmid:8887738 |
| Stiris TA et al. | Effects of dexamethasone on retinal and choroidal blood flow during normoxia and hyperoxia in newborn piglets. | 1996 | Pediatr. Res. | pmid:8888288 |
| Myers SI et al. | Estrogen increases male rat aortic endothelial cell (RAEC) PGI2 release. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8888351 |
| Chou TC et al. | The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation. | 1996 | Thromb. Res. | pmid:8897698 |
| Harada Y et al. | Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. | 1996 | Prostaglandins | pmid:8900441 |
| Karck U et al. | PGE2 and PGF2 alpha release by human peritoneal macrophages in endometriosis. | 1996 | Prostaglandins | pmid:8900443 |
| Livingston ER et al. | Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. | 1996 | Circulation | pmid:8901751 |
| Serebruany VL et al. | Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swine. | 1996 | Pharmacology | pmid:8902873 |
| Parnas BL et al. | Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus. | 1996 | J. Nat. Prod. | pmid:8904845 |
| Martin W et al. | Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators. | 1996 | Eur J Cardiothorac Surg | pmid:8905281 |
| Montuschi P et al. | Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis. | 1996 | Eur. J. Pharmacol. | pmid:8905345 |
| Nishisho T et al. | Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. | 1996 | Neurosurgery | pmid:8905750 |
| Berdeaux O et al. | Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production. | 1996 | J. Lipid Res. | pmid:8906600 |
| Schmid P et al. | Passive smoking and platelet thromboxane. | 1996 | Thromb. Res. | pmid:8907294 |
| Chello M et al. | Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease. | 1996 | J. Cardiovasc. Pharmacol. | pmid:8907804 |
| Szekacs B et al. | Prostacyclin and thromboxane production of rat and cat arterial tissue is altered independently by several vasoactive substances. | 1996 | Prostaglandins | pmid:8908622 |
| Ferrándiz ML et al. | Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice. | 1996 | J. Pharm. Pharmacol. | pmid:8910867 |
| Okada M et al. | Two mechanisms for platelet-mediated killing of tumour cells: one cyclo-oxygenase dependent and the other nitric oxide dependent. | 1996 | Immunology | pmid:8911154 |
| Shibasaki T et al. | Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside. | 1996 | Am. J. Nephrol. | pmid:8919236 |